查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594616

腫瘤營養市場：按癌症、給藥途徑和最終用戶分類 - 全球預測 2025-2030

Oncology Nutrition Market by Cancer (Breast, Head & Neck, Liver), Route of Administration (Oral, Parenteral), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腫瘤營養市場價值為30.6億美元，預計到2024年將達到33.2億美元，複合年成長率為8.61%，到2030年將達到54.6億美元。

腫瘤營養報告包括客製化飲食策略，以支持癌症患者的治療和康復，重點是改善營養狀況、控制副作用和提高生活品質。這些營養需求源於癌症引起的代謝變化和治療相關的副作用，因此量身定做的營養干預措施對於維持體重、肌肉質量和免疫功能至關重要。其應用範圍從個人化飲食計劃和補充到解決營養不良和惡病質。最終用途範圍包括醫院、專科診所和居家照護機構，為患者提供全面的營養支援。該市場的關鍵成長要素包括全球癌症發病率增加、人們對營養在癌症治療中重要性的認知不斷提高以及營養診斷技術的進步。新的商機在於透過遺傳和微生物組資料進行個人化營養治療，這使得個人化計畫能夠顯著改善治療結果。利用這些機會的研究和開發工作包括投資與腫瘤學家和營養學家的研究合作，以製定精確的飲食指南，並與生物技術公司建立營養基因組解決方案的合作關係，其中包括：儘管存在成長潛力，但高治療成本、報銷問題以及癌症類型飲食需求差異等挑戰可能會阻礙市場擴張。可以在植物來源營養食品、非侵入性營養評估工具和遠端患者監護數位平台等領域進行創新，以最佳化治療計劃。深入研究針對癌症特定需求的機能性食品也是一個有前景的研究途徑。腫瘤營養市場的本質是動態的，受到強調綜合護理的不斷發展的醫療範式的驅動。要在這個市場取得成功，需要隨時了解臨床研究、監管發展和消費者偏好，以保持競爭力，並在這個快速成長的細分市場中推動有意義的患者治療結果。

主要市場統計
基準年[2023] 30.6億美元
預測年份 [2024] 33.2億美元
預測年份 [2030] 54.6億美元
複合年成長率（%） 8.61%

市場動態：快速發展的腫瘤營養市場的關鍵市場洞察

供需的動態交互作用正在改變腫瘤營養市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 癌症患者增加
    • 癌症患者對營養支持的需求不斷成長
    • 提高先進醫療設施的認知度和可近性
  • 市場限制因素
    • 癌症患者的優質營養產品高成本
  • 市場機會
    • 癌症患者營養補充品的進展
    • 為接受切除術的癌症患者提供增強免疫的營養補充劑
  • 市場問題
    • 製造複雜性

波特五力：駕馭腫瘤營養市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解腫瘤營養市場的外部影響

外部宏觀環境因素在塑造腫瘤營養市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解腫瘤營養市場的競爭格局

對腫瘤營養市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：腫瘤營養市場供應商的績效評估

FPNV定位矩陣是評估腫瘤營養市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃腫瘤營養市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，腫瘤營養市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症發生率上升
      • 腫瘤患者對營養支持的需求增加
      • 提高意識和使用先進醫療設施的機會
    • 抑制因素
      • 腫瘤學優質營養產品高成本
    • 機會
      • 腫瘤營養製劑的進展
      • 接受切除術的癌症患者的免疫增強組合
    • 任務
      • 與生產相關的複雜性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章腫瘤營養市場：依癌症分類

  • 介紹
  • 胸部
  • 頭部和頸部
  • 肝
  • 肺
  • 胰臟
  • 胃和消化系統

第7章腫瘤營養市場：依給藥途徑

  • 介紹
  • 口服
  • 胃腸外的

第8章腫瘤營養市場：依最終用戶分類

  • 介紹
  • 居家醫療
  • 醫院
  • 專科診所

第9章北美及南美腫瘤營養市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太腫瘤營養市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的腫瘤營養市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • B. Braun SE
  • Baxter International, Inc.
  • BioSig Technologies, Inc.
  • Danone SA
  • FMC Corporation
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Healios Oncology Nutrition, LLC
  • Hormel Foods Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle SA
  • Nutra Healthcare Private Limited
  • OnCore Nutrition
Product Code: MRR-036C5CF3A8D2

The Oncology Nutrition Market was valued at USD 3.06 billion in 2023, expected to reach USD 3.32 billion in 2024, and is projected to grow at a CAGR of 8.61%, to USD 5.46 billion by 2030.

The scope of oncology nutrition encompasses dietary strategies tailored to support cancer patients throughout their treatment and recovery, focusing on improving nutritional status, managing side effects, and enhancing quality of life. The necessity of such nutrition arises from cancer-induced metabolic changes and treatment-related side effects, making tailored nutritional interventions essential for maintaining body weight, muscle mass, and immune function. Applications range from individualized meal planning and supplementation to addressing malnutrition and cachexia. End-use scope includes hospitals, specialty clinics, and home care settings providing comprehensive nutritional support to patients. Key growth factors in this market include increasing global cancer prevalence, heightened awareness of the importance of nutrition in cancer care, and technological advancements in nutritional diagnostics. Emerging opportunities lie in personalized nutrition based on genetic and microbiome data, which enables individualized plans that can significantly improve therapeutic outcomes. Recommendations for capitalizing on these opportunities include investing in research collaborations with oncologists and dietitians to develop precise dietary guidelines and fostering partnerships with biotechnology firms for nutritional genomics solutions. Despite the growth potential, challenges such as high treatment costs, reimbursement issues, and variability in dietary requirements across different cancer types may hinder market expansion. Innovations can be pursued in the areas of plant-based nutritional supplements, non-invasive nutritional assessment tools, and digital platforms for remote patient monitoring to optimize treatment plans. Delving into functional foods tailored for cancer-specific needs also presents a promising research avenue. The nature of the oncology nutrition market is dynamic, driven by evolving healthcare paradigms that emphasize integrative care. Success in this market necessitates staying abreast of clinical research, regulatory developments, and consumer preferences to remain competitive and drive meaningful patient outcomes in a burgeoning field.

KEY MARKET STATISTICS
Base Year [2023] USD 3.06 billion
Estimated Year [2024] USD 3.32 billion
Forecast Year [2030] USD 5.46 billion
CAGR (%) 8.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oncology Nutrition Market

The Oncology Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer cases
    • Growing demand for nutritional feeding for oncology patients
    • Increased awareness and accessibility to advanced healthcare facilities
  • Market Restraints
    • High cost of premium nutrition products for oncology
  • Market Opportunities
    • Advancement of oncology nutritional feeding formulas
    • Immune-enhancing formulas for patients with cancer undergoing esophagectomy
  • Market Challenges
    • Complexities associated with the production

Porter's Five Forces: A Strategic Tool for Navigating the Oncology Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oncology Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oncology Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oncology Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oncology Nutrition Market

A detailed market share analysis in the Oncology Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oncology Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oncology Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oncology Nutrition Market

A strategic analysis of the Oncology Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oncology Nutrition Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Baxter International, Inc., BioSig Technologies, Inc., Danone S.A., FMC Corporation, Fresenius Kabi AG, Global Health Products, Inc., Healios Oncology Nutrition, LLC, Hormel Foods Corporation, Meiji Holdings Co., Ltd., Nestle S.A., Nutra Healthcare Private Limited, and OnCore Nutrition.

Market Segmentation & Coverage

This research report categorizes the Oncology Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Cancer, market is studied across Breast, Head & Neck, Liver, Lung, Pancreatic, and Stomach & Gastrointestinal.
  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on End-user, market is studied across Home Care, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer cases
      • 5.1.1.2. Growing demand for nutritional feeding for oncology patients
      • 5.1.1.3. Increased awareness and accessibility to advanced healthcare facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of premium nutrition products for oncology
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement of oncology nutritional feeding formulas
      • 5.1.3.2. Immune-enhancing formulas for patients with cancer undergoing esophagectomy
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with the production
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oncology Nutrition Market, by Cancer

  • 6.1. Introduction
  • 6.2. Breast
  • 6.3. Head & Neck
  • 6.4. Liver
  • 6.5. Lung
  • 6.6. Pancreatic
  • 6.7. Stomach & Gastrointestinal

7. Oncology Nutrition Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Parenteral

8. Oncology Nutrition Market, by End-user

  • 8.1. Introduction
  • 8.2. Home Care
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Oncology Nutrition Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oncology Nutrition Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oncology Nutrition Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun SE
  • 3. Baxter International, Inc.
  • 4. BioSig Technologies, Inc.
  • 5. Danone S.A.
  • 6. FMC Corporation
  • 7. Fresenius Kabi AG
  • 8. Global Health Products, Inc.
  • 9. Healios Oncology Nutrition, LLC
  • 10. Hormel Foods Corporation
  • 11. Meiji Holdings Co., Ltd.
  • 12. Nestle S.A.
  • 13. Nutra Healthcare Private Limited
  • 14. OnCore Nutrition

LIST OF FIGURES

  • FIGURE 1. ONCOLOGY NUTRITION MARKET RESEARCH PROCESS
  • FIGURE 2. ONCOLOGY NUTRITION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ONCOLOGY NUTRITION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ONCOLOGY NUTRITION MARKET DYNAMICS
  • TABLE 7. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY BREAST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HEAD & NECK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PANCREATIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY STOMACH & GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023